Skip to main content
Log in

Small phenolic and indolic gut-dependent molecules in the primate central nervous system: levels vs. bioactivity

  • Original Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

Introduction

A rapidly growing body of data documents associations between disease of the brain and small molecules generated by gut-microbiota (GMB). While such metabolites can affect brain function through a variety of mechanisms, the most direct action would be on the central nervous system (CNS) itself.

Objective

Identify indolic and phenolic GMB-dependent small molecules that reach bioactive concentrations in primate CNS.

Methods

We conducted a PubMed search for metabolomic studies of the primate CNS [brain tissue or cerebrospinal fluid (CSF)] and then selected for phenolic or indolic metabolites that (i) had been quantified, (ii) were GMB-dependent. For each chemical we then conducted a search for studies of bioactivity conducted in vitro in human cells of any kind or in CNS cells from the mouse or rat.

Results

36 metabolites of interests were identified in primate CNS through targeted metabolomics. Quantification was available for 31/36 and in vitro bioactivity for 23/36. The reported CNS range for 8 metabolites 2-(3-hydroxyphenyl)acetic acid, 2-(4-hydroxyphenyl)acetic acid, 3-(3-hydroxyphenyl)propanoic acid, (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid [caffeic acid], 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 2-acetamido-3-(1H-indol-3-yl)propanoic acid [N-acetyltryptophan], 1H-indol-3-yl hydrogen sulfate [indoxyl-3-sulfate] overlapped with a bioactive concentration. However, the number and quality of relevant studies of CNS neurochemistry as well as of bioactivity were highly limited. Structural isomers, multiple metabolites and potential confounders were inadequately considered.

Conclusion

The potential direct bioactivity of GMB-derived indolic and phenolic molecules on primate CNS remains largely unknown. The field requires additional strategies to identify and prioritize screening of the most promising small molecules that enter the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Provided.

Code availability

Not applicable.

References

Download references

Funding

Funded by the Department of Medical Research DVA.

Author information

Authors and Affiliations

Authors

Contributions

GEJ conceived the study and wrote the first draft of the manuscript. DX conducted the data extraction. All authors read, provided critical review, and approved the final manuscript.

Corresponding author

Correspondence to George E. Jaskiw.

Ethics declarations

Conflict of interest

Curtis J. Donskey has received research funding from Clorox, Pfizer, and PDI. All other authors report no relevant conflicts of interest.

Ethical approval

Not applicable. This is a retrospective, study based on publicly available literature. There was no patient contact and no protected health information was used. Our Institutional Review Board has determined that such studies do not require review.

Consent to participate

Not applicable. This is a retrospective, study based on publicly available literature. There was no patient contact, and no protected health information was used.

Consent for publication

Not applicable. This is a retrospective, study based on publicly available literature. There was no patient contact, and no protected health information was used.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 511 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jaskiw, G.E., Xu, D., Obrenovich, M.E. et al. Small phenolic and indolic gut-dependent molecules in the primate central nervous system: levels vs. bioactivity. Metabolomics 18, 8 (2022). https://doi.org/10.1007/s11306-021-01866-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11306-021-01866-4

Keywords

Navigation